State Street
TTPH

State Street’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

State Street’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,656
Closed -$26K – 3836
2019
Q2 		$26K Sell
2,656
-52,141
-95% -$960K ﹤0.01% 3762
2019
Q1 		$1.47M Sell
54,797
-7,922
-13% -$202K ﹤0.01% 3254
2018
Q4 		$1.42M Buy
62,719
+2,535
+4% +$99.1K ﹤0.01% 3240
2018
Q3 		$3.32M Buy
60,184
+2,404
+4% +$154K ﹤0.01% 3054
2018
Q2 		$4.12M Buy
57,780
+1,351
+2% +$95.4K ﹤0.01% 2960
2018
Q1 		$3.46M Buy
56,429
+8,534
+18% +$749K ﹤0.01% 2950
2017
Q4 		$6.03M Buy
47,895
+1,381
+3% +$177K ﹤0.01% 2697
2017
Q3 		$6.36M Buy
46,514
+10,259
+28% +$1.37M ﹤0.01% 2677
2017
Q2 		$5.17M Buy
36,255
+2,178
+6% +$337K ﹤0.01% 2716
2017
Q1 		$6.26M Sell
34,077
-1,472
-4% -$165K ﹤0.01% 2587
2016
Q4 		$2.86M Buy
35,549
+569
+2% +$45K ﹤0.01% 2963
2016
Q3 		$2.68M Buy
34,980
+206
+0.6% +$16.5K ﹤0.01% 2859
2016
Q2 		$2.99M Buy
34,774
+179
+0.5% +$16.4K ﹤0.01% 2875
2016
Q1 		$3.21M Sell
34,595
-33,883
-49% -$3.38M ﹤0.01% 2787
2015
Q4 		$13.7M Sell
68,478
-114,666
-63% -$22.9M ﹤0.01% 1989
2015
Q3 		$27.3M Buy
183,144
+115,154
+169% +$84.5M ﹤0.01% 1537
2015
Q2 		$64.5M Sell
67,990
-3,287
-5% -$2.69M 0.01% 1114
2015
Q1 		$52.2M Buy
71,277
+10,531
+17% +$7.91M 0.01% 1209
2014
Q4 		$48.2M Buy
60,746
+47,262
+351% +$25.4M ﹤0.01% 1246
2014
Q3 		$5.38M Buy
13,484
+1,354
+11% +$363K ﹤0.01% 2502
2014
Q2 		$3.27M Buy
12,130
+4,206
+53% +$903K ﹤0.01% 2819
2014
Q1 		$1.73M Buy
7,924
+2,111
+36% +$588K ﹤0.01% 3121
2013
Q4 		$1.57M Buy
5,813
+2,202
+61% +$525K ﹤0.01% 3159
2013
Q3 		$824K Buy
3,611
+2,451
+211% +$428K ﹤0.01% 3279
2013
Q2 		$164K Buy
+1,160
New +$184K ﹤0.01% 3358

Other funds holding TTPH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street's TTPH Position: Q3 2019 in Review

State Street sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2019, closing a stake of 2,656 shares — an estimated $26K sold.

State Street first reported a position in TTPH in Q2 2013 and held it in 25 quarters. The position peaked at $64.5M in Q2 2015. 26 funds tracked by Wall St. Rank hold TTPH as of Q3 2019.

  • State Street reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • State Street sold 2,656 Tetraphase Pharmaceuticals, Inc. shares in Q3 2019, an estimated $26K.
  • State Street first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and held it in 25 quarters.
  • State Street's Tetraphase Pharmaceuticals, Inc. position peaked at $64.5M in Q2 2015.
  • 26 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2019.

Based on State Street's 13F filing for Q3 2019, filed 14 Nov 2019.